Grüns acquired by Unilever for $1.2B: What we can all learn from this

I write on startups, capital markets, and finance. I also share lessons from advising and operating private businesses doing $10M-250M+ in revenue. My goal is to make the complex simple and the abstract concrete.

By now we’ve probably seen the headlines and the growth stats circulating. $300M in annualized revenue by month 24. Profitable within 14 months of launch. 1M+ customers. 10M+ gummies shipped per day. The #1 Greens Supplement on Amazon. Nationwide at Target, Walmart, Costco, Sam’s Club, Sprouts.

I’m not going to rehash the deal announcement. What I want to double click on is what this acquisition actually tells us, both for operators building consumer brands and for investors allocating capital into the space. Because the Grüns story is interesting on its own, but the context surrounding it is where we should focus our attention.

Unilever is not the same company it was 18 months ago

This is the part most people covering the deal are glossing over, and it’s the part that matters most if you’re trying to understand why this acquisition happened now.

In December 2025, Unilever completed the demerger of its entire ice cream business. Magnum, Ben & Jerry’s, all of it. That’s now a separately traded public company on the Amsterdam Stock Exchange. Then last week, they announced a roughly $45B deal to merge their entire food portfolio with McCormick. Hellmann’s, Knorr, Marmite, Horlicks. Unilever shareholders will own about 55% of the combined McCormick entity, and Unilever receives roughly $16B in cash. Throughout 2025 and into 2026, they’ve also been divesting non-core brands. Conimex, The Vegetarian Butcher, Kate Somerville, their Indonesia tea business.

What’s left is a fundamentally different company focused on: beauty, health & wellness, personal care, home care.

CEO (Fernando Fernandez) has been explicit about where the capital goes from here. More beauty and wellbeing, more personal care, disproportionate investment in the U.S. and India, and a sharper focus on premium segments and digital commerce. In 2025, beauty & wellbeing grew 4%. Personal care grew approx 5%. Foods declined 3%+. The company is making structural decisions about what kind of business it wants to be for the next decade, and it is shedding tens of billions of dollars in assets to make that decision irreversible.

I think about this from the perspective of someone who works with consumer brands every day. When a company the size of Unilever (roughly $55B in revenue), decides to concentrate rather than diversify, it tells you something about where the durable margin pools are forming in consumer. They looked at their entire portfolio and decided that beauty, wellness, and personal care is where pricing power, consumer loyalty, and margin expansion live over the long term. Everything else, including some of the most iconic food brands on earth, was worth more to someone else.

Grüns is one of the first moves Unilever is making as a pureplay personal care and wellbeing company. The strategic intent behind it is louder than the deal terms.

The wellness portfolio they’ve assembled is significant

Look at what Unilever has built over the past few years. Liquid I.V. became a billion-dollar brand under their ownership in 2025. OLLY crossed $500M in sales. Nutrafol continues double-digit growth (and likely approaching $1B+ in rev). K18 in haircare is growing strong double-digit. Dr. Squatch was acquired for roughly $1.5B. Wild in personal care. Minimalist in India. And now Grüns.

Every one of these brands had something in common before Unilever acquired them: a clear category position, a direct consumer relationship, strong retail velocity, and a financial plan that was already working. Unilever bought these brands because the model was clearly proven. The acquisition thesis is about adding distribution muscle and international infrastructure to businesses that have already demonstrated their economics.

The bar for what “acquirable” means in consumer wellness has moved materially higher than it was even 3 years ago. And the brands that clear that bar are being rewarded for it.

Worth noting: Unilever’s decision to exit food is one company’s portfolio decision. The strategic appetite for food, beverage, pet, and broader CPG is very much alive elsewhere. Mars acquired Kellanova for $36B. PepsiCo bought Siete. Nestlé, General Mills, and others continue to deploy capital across food and beverage categories. The acquirer base is deep, and it extends well beyond wellness. What’s consistent across all of these deals, regardless of category, is the profile of the brands getting acquired: strong economics, real velocity, clean financials, and a model that works before the strategic shows up.

What made Grüns acquirable

The growth numbers are getting all the attention, but the operational architecture underneath is beyond impressive.

The founder has talked publicly about running the business on a minimum 3x LTV/CAC ratio. In a supplement category where most brands (historically) scale on spend and figure out the economics later, Grüns scaled on unit economics and let the growth follow.

I see versions of this decision constantly in the brands we work with. The pressure to grow is real, especially when the category is hot and capital is available. The brands that hold the line on customer economics, even when it means slower growth in a given quarter, tend to be the ones with better margin profiles, cleaner balance sheets, and more options when it matters.

The SKU architecture was focused. One hero product, then purposeful line extensions. Kids. Cognitive support. Immune. Energy. Each mapped to a real consumer use case. No sprawl or filler. Merchandising and planning done right. I think about the number of brands in the ecosystem that could benefit from this kind of restraint. The instinct to add SKUs is strong when you’re growing. Every retail buyer asks what’s next. Every investor wants to see the pipeline. The brands that hold the line on portfolio discipline tend to be the ones with better gross margins, cleaner inventory, and simpler retail execution. That restraint is hard to maintain, and it shows up in the financials when it’s present.

The retail expansion followed the demand signal. Target went nationwide across all 1,900 locations. Walmart scaled from roughly 2,000 to 3,500+ doors in about 6 months. Sam’s Club came on with multiple SKUs. Retailers kept adding distribution because the brand was driving aisle traffic faster than the category average. That’s pull-through. You earn that with velocity, and it’s one of the things a strategic acquirer is most interested in validating, because it tells them the growth will continue under their ownership with more distribution behind it.

And the brand hit profitability within 14 months. This is perhaps the most impressive part. Subscription and supplement brands can escape velocity quickly but profitability is hard at the growth rate Grüns operated with. That profile is what makes a strategic acquirer comfortable underwriting a premium. Unilever is buying a business they can easily feed. All key parts are working. The integration risk is lower when scaled economics are already proven.

The atoms vs. bits story (focused on CPG)

Here’s where the Grüns acquisition fits into a capital markets story that extends well beyond any single category.

The iShares software ETF is down over 20% YTD. Since its Sep 2025 peak, it’s fallen roughly 30%. That represents about $2T in market cap erased. For the first time in 20 years, software companies now trade at a discount to the S&P 500. Public SaaS median EV/Revenue multiples have compressed to around 3.5x. Private software is in worse shape. Down rounds are expected to increase. VC deal flow in software fell from roughly $150B across 5,500 deals in 2021 to about $80B across 1,500 deals by mid-2025. The IPO window has been functionally closed for most software companies for the last 18 months.

The core driver is AI repricing the entire category. The cost of building software is approaching zero. The moat around many SaaS businesses got materially thinner overnight. Investors are applying lower terminal values, lower free cash flow projections, and higher discount rates across the sector. Capital is rotating out, and the rotation is accelerating.

Now look at the other side.

Consumer brands across CPG; notably in wellness, food, beverage, personal care, and pet are generating real exits at premium valuations with clean liquidity events. Grüns to Unilever. Poppi to PepsiCo for close to $2B. Huel to Danone for roughly $1.2B. Dr. Squatch to Unilever for roughly $1.5B. Siete to PepsiCo. Kellanova to Mars for $36B. Ferrero acquired WK Kellogg for roughly $2B. Hershey bought LesserEvil. Health-Ade transacted at $500M. Carlsberg acquired Britvic for over $4B. These are physical products, real supply chains, brand moats, tangible margins. In short: these are emerging and established brands that are durable assets.

The breadth matters. These deals span many sectors across CPG. The strategic appetite is category-agnostic. What’s consistent is the profile: strong economics, real velocity, proven model.

The consumer deals are trading at 3-4x revenue with real cash changing hands. Software is at roughly the same multiples with far fewer actual liquidity events and a more uncertain forward trajectory.

I think we’re in the early stages of a meaningful capital rotation back into consumer and CPG. AI compressed the value of building software. Building a consumer brand with real product differentiation, a loyal customer base, proven retail velocity, and clean unit economics remains difficult to replicate, difficult to disrupt, and increasingly attractive to the largest strategic acquirers in the world. The deal flow over the past 18 months has made that case more clearly than any pitch deck could. The exits are real. The multiples are holding. And the strategic appetite is accelerating.

For investors and capital allocators in our network, including the private credit and ABL community that finances many of these brands, the signal is worth paying attention to. The liquidity pathways in consumer are real and getting more frequent. The companies being acquired are generating genuine returns. And the acquirers are not slowing down.

What founders and operators can learn from this

The consumer M&A corridor is active across categories. The largest strategics in the world are deploying acquisition capital at premium multiples, and they’re doing it across the full consumer landscape. That has downstream implications for how brands in the $20M to $100M range think about capitalization, margin structure, and channel strategy.

The brands commanding those multiples share common traits. Focused product architecture. Real retail velocity. Clean unit economics. A DTC relationship that gives you data and margin, and a retail presence that proves pull-through. Every acquisition I’ve mentioned in this piece had all of these in place before the strategic showed up. The acquirer was buying a model that was already working and adding distribution muscle to it.

Financial infrastructure matters as much as growth. When the conversation comes, and in this environment the conversations are coming, the acquirer is underwriting your cash conversion cycle, gross margin durability, channel mix, customer economics, etc. They want to see that the business funds itself, that the unit economics hold at scale, and that the financial reporting is clean enough to diligence quickly. Me and my team work with brands in this category every day. The ones building that financial architecture while they’re growing are the ones who will have options when the moment arrives.

These are the early days. There will continue to be a lot of positive momentum (and capital) flowing into CPG in the coming years. A real validation for the builders and operators working tirelessly to create the best products in the world, drive innovation, and delight customers.